Zalewska-Piątek Beata
Department of Molecular Biotechnology and Microbiology, Chemical Faculty, Gdańsk University of Technology, Narutowicza 11/12, 80-233 Gdańsk, Poland.
Pharmaceuticals (Basel). 2023 Nov 22;16(12):1638. doi: 10.3390/ph16121638.
The increasing drug resistance of bacteria to commonly used antibiotics creates the need to search for and develop alternative forms of treatment. Phage therapy fits this trend perfectly. Phages that selectively infect and kill bacteria are often the only life-saving therapeutic option. Full legalization of this treatment method could help solve the problem of multidrug-resistant infectious diseases on a global scale. The aim of this review is to present the prospects for the development of phage therapy, the ethical and legal aspects of this form of treatment given the current situation of such therapy, and the benefits of using phage products in persons for whom available therapeutic options have been exhausted or do not exist at all. In addition, the challenges faced by this form of therapy in the fight against bacterial infections are also described. More clinical studies are needed to expand knowledge about phages, their dosage, and a standardized delivery system. These activities are necessary to ensure that phage-based therapy does not take the form of an experiment but is a standard medical treatment. Bacterial viruses will probably not become a miracle cure-a panacea for infections-but they have a chance to find an important place in medicine.
细菌对常用抗生素的耐药性不断增加,这就需要寻找和开发替代治疗方法。噬菌体疗法完全符合这一趋势。选择性感染并杀死细菌的噬菌体往往是唯一能挽救生命的治疗选择。这种治疗方法的全面合法化有助于在全球范围内解决多重耐药性传染病问题。本综述的目的是介绍噬菌体疗法的发展前景、鉴于这种疗法的现状其在伦理和法律方面的情况,以及在现有治疗选择已经用尽或根本不存在的人群中使用噬菌体产品的益处。此外,还描述了这种疗法在对抗细菌感染方面面临的挑战。需要更多的临床研究来扩大对噬菌体、其剂量和标准化给药系统的了解。这些活动对于确保基于噬菌体的疗法不采取实验形式而是成为标准医学治疗是必要的。细菌病毒可能不会成为一种神奇的疗法——治疗感染的万灵药——但它们有机会在医学中占据重要地位。